Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Palliative and end-of-life care indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Breathlessness in advanced illness

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Acute severe respiratory distress

Sudden breathlessness, stridor, haemoptysis, pleuritic pain, unilateral absent breath sounds, cyanosis, exhaustion, altered consciousness or haemodynamic instability may represent a reversible respiratory emergency.

Action: Use ABCDE assessment, sit the person upright when tolerated, provide calm continuous support and activate emergency help within the agreed treatment ceiling. Give oxygen for hypoxaemia, treat the suspected cause promptly and provide symptom relief in parallel; do not assume acute deterioration is terminal solely because illness is advanced.

Overview

Assess breathlessness as a subjective multidimensional symptom, treat reversible emergencies and disease mechanisms, combine non-pharmacological measures with proportionate opioid or oxygen trials, and document goal-concordant escalation before crisis.

Breathlessness is an interaction between physiological drive, mechanical capacity and the brain's interpretation of threat. Severity may be disproportionate to saturation, and a person with marked hypoxaemia may report little distress. Ask the patient how breathing feels, what they fear and what activity is lost. Record rest and exertional pattern, recovery time and the smallest task that triggers symptoms.

Acute change requires a conventional differential diagnosis. Pneumonia, embolism, pneumothorax, pulmonary oedema, arrhythmia, anaemia, effusion, airway obstruction, hypercalcaemia and opioid toxicity remain treatable in advanced disease. Establish whether hospital investigation, non-invasive ventilation, drainage, transfusion or other intervention fits the person's goals, but provide immediate comfort and explanation while the decision is made.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Palliative and end-of-life careOriginal SBA

Non-hypoxaemic refractory breathlessness

A patient with advanced lung disease remains distressed by breathlessness despite disease optimisation, but oxygen saturation is normal. What is the best first symptom-focused approach?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Palliative and end-of-life care topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG31 care of dying adultsIndividual breathlessness assessment, non-drug care, opioid, benzodiazepine and oxygen considerations.
  • NICE NG115 COPD recommendationsOxygen targets, pulmonary rehabilitation, inhaled treatment and advanced COPD care.
  • Scottish palliative breathlessness guidelineNon-pharmacological care, opioid and anxiolytic examples and oxygen principles.
  • GMC end-of-life treatment guidanceGoal-concordant treatment decisions, capacity and continuing symptom care.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Non-pharmacological management should be taught before crisis. Sit upright with supported arms, reduce constrictive clothing, use cool airflow across the face, slow expiration through pursed lips and pace activity with planned rests. An occupational therapist or physiotherapist can teach energy conservation, walking aids and recovery positions. Caregivers benefit from rehearsing short prompts rather than repeatedly instructing the person to take deep breaths.

Oxygen is a treatment for hypoxaemia, not a universal anxiolytic. Check saturation and the clinical context. Give oxygen in an acute hypoxaemic emergency according to the relevant target range, including lower targets when known hypercapnic respiratory failure requires them. For chronic palliative symptoms without hypoxaemia, compare an oxygen trial with fan or room air and continue only if the patient has meaningful benefit and equipment burden is acceptable.

Opioids reduce the central perception of breathlessness and ventilatory drive at low carefully titrated doses without necessarily causing clinically important respiratory depression. In an opioid-naive frail adult, palliative formularies may start immediate-release oral morphine around 2 to 2.5 mg as needed or at a defined interval, then review. A person already taking opioid requires calculation from current exposure. Renal failure can make morphine unsafe; seek palliative and pharmacy advice for an alternative.

An escalation plan should distinguish treatment and location. A person may decline intubation but accept antibiotics, diuresis, pleural drainage or time-limited non-invasive ventilation. DNACPR does not settle these choices. Document capacity, goals, therapies likely to help, what will not be offered, preferred setting, rescue treatment and whom carers contact day and night. Review after each major episode because prognosis and tolerance can change.

Key points

  • Breathlessness is the patient's perception; respiratory rate, oxygen saturation and imaging help find mechanisms but do not measure distress completely.
  • First-line assessment defines onset, triggers, positional and exertional pattern, associated pain, cough, haemoptysis, wheeze, fever and current treatment ceiling.
  • Treat reversible causes when likely benefit matches goals: bronchodilator, antibiotic, diuretic, anticoagulation, drainage, transfusion, stent or radiotherapy may be appropriate.
  • First-line non-drug care is upright positioning, cool facial airflow, calm coaching, loosened clothing, pacing, breathing control and rapid access to a trusted contact.
  • A handheld fan directed across the central face can reduce breathlessness perception even when oxygen saturation is normal.
  • Give supplemental oxygen for documented or strongly suspected hypoxaemia; in non-hypoxaemic breathlessness, oxygen is not routinely better than air and should be a time-limited trial only when benefit is demonstrated.
  • Low-dose morphine can reduce refractory breathlessness after mechanism treatment and non-drug measures, with lower starting exposure in frailty and renal or hepatic caution.
  • Benzodiazepines are not first-line for breathlessness itself; reserve them for severe associated anxiety or panic after safer measures and monitor combined respiratory sedation.
  • The gold-standard plan records reversible causes, non-drug techniques, medicine and oxygen trials, rescue instructions, escalation ceiling and review of function and toxicity.

Aetiology

01

Progressive respiratory disease

COPD, interstitial lung disease, pleural disease, tumour obstruction and lymphangitic spread reduce ventilatory reserve and increase respiratory effort.

02

Cardiovascular and haematological causes

Heart failure, pericardial disease, pulmonary embolism and severe anaemia impair oxygen delivery or raise pulmonary pressures and can coexist.

03

Reversible acute complication

Infection, bronchospasm, pneumothorax, effusion, mucus plugging, arrhythmia, acidosis and medication toxicity can cause rapid deterioration in advanced illness.

04

Functional and emotional contributors

Deconditioning, cachexia, anxiety, panic, poor sleep and fear of suffocation amplify neural respiratory drive and reduce confidence in ordinary activity.

Pathophysiology

  1. 1
    Drive-load mismatch

    Breathlessness intensifies when respiratory drive rises but weakened or obstructed muscles cannot generate the ventilation the brain expects.

  2. 2
    Gas-exchange impairment

    Ventilation-perfusion mismatch, diffusion limitation or shunt causes hypoxaemia, while alveolar hypoventilation causes carbon-dioxide retention and acidosis.

  3. 3
    Mechanoreceptor signalling

    Hyperinflation, stiff lungs, pleural restriction and muscle fatigue generate afferent signals interpreted as increased work or chest tightness.

  4. 4
    Central perceptual processing

    Prior frightening episodes, attention, emotion and expectation alter cortical interpretation, explaining severe distress despite modest physiological change or vice versa.

  5. 5
    Vicious cycle of panic

    Fear increases respiratory rate, muscle tension and avoidance, worsening inefficiency and deconditioning and then reinforcing fear of the next episode.

Clinical features and red flags

Refractory breathlessness

Distress persists despite optimal treatment of reversible and disease mechanisms, prompting combined non-drug and symptom-directed care.

Hypoxaemic pattern

Low saturation, cyanosis, exertional desaturation or gas-exchange disease supports oxygen assessment but does not by itself define symptom intensity.

Hypercapnic deterioration

Drowsiness, headache, bounding pulse, flap and shallow breathing in COPD, obesity hypoventilation or neuromuscular disease suggests carbon-dioxide retention.

Panic-associated episode

Rapid upper-chest breathing, tingling, fear and symptom escalation after threat cues suggests a panic loop once urgent physiology is addressed.

Pleural or cardiac congestion

Orthopnoea, dullness, reduced breath sounds, oedema, raised venous pressure or rapid weight gain suggests drainable or diuretic-responsive fluid.

Respiratory exhaustionRed flag

Falling effort, silent chest, altered consciousness or inability to speak after sustained distress signals impending ventilatory failure.

Red flags requiring action

  • Stridor, facial or neck swelling, inability to speak, drooling or rapidly worsening upper-airway noise requires immediate airway and senior oncological assessment.
  • Sudden pleuritic pain, syncope, unilateral leg swelling or unexplained tachycardia suggests pulmonary embolism and needs goal-concordant urgent evaluation.
  • Acute unilateral chest pain with reduced breath sounds and instability suggests tension pneumothorax and requires emergency decompression assessment.
  • Fever, purulent sputum, shock or new focal chest signs may indicate infection requiring prompt antibiotics and sepsis care when consistent with goals.
  • Respiratory exhaustion, falling rate, confusion, cyanosis or rising carbon dioxide is more dangerous than visible tachypnoea alone.
  • Drowsiness and respiratory rate below 8 after opioid or sedative exposure suggests toxicity and requires airway support and proportionate reversal.
  • Major haemoptysis requires the catastrophic-bleed plan, presence and airway positioning rather than leaving the patient to fetch complex medicines.

Investigations

  1. 01
    First-line bedside respiratory assessmentFirst stepFirst line
    Why
    Measure rate, effort, speech, arousal, oxygen saturation, pulse, pressure and temperature and examine airway, chest, heart, legs and fluid status.
    Interpretation and limitations
    Instability, stridor, unilateral signs or exhaustion triggers emergency treatment; normal saturation does not exclude severe subjective breathlessness.
  2. 02
    Patient-reported severity and function
    Why
    Use a consistent scale plus an activity, recovery time or sleep outcome meaningful to the person.
    Interpretation and limitations
    Treatment success is easier breathing or improved function with acceptable harm, not a mandatory change in saturation.
  3. 03
    ECG and chest imaging
    Why
    Investigate arrhythmia, ischaemia, infection, oedema, effusion, pneumothorax, tumour or another actionable cardiopulmonary cause.
    Interpretation and limitations
    Select radiograph, ultrasound or CT by urgency and goal; avoid imaging when no possible result would change goal-concordant treatment.
  4. 04
    Targeted blood tests
    Why
    Check anaemia, infection, renal function, electrolytes, calcium, acidosis or cardiac markers when a treatable cause is plausible.
    Interpretation and limitations
    Renal and hepatic results also determine opioid and benzodiazepine safety; trend matters during acute deterioration.
  5. 05
    Arterial or venous blood gas
    Why
    Assess carbon-dioxide retention, acidosis and severity when ventilatory failure or non-invasive ventilation is being considered.
    Interpretation and limitations
    Interpret with baseline COPD or neuromuscular disease and the agreed escalation plan; oxygen saturation alone cannot quantify hypercapnia.
  6. 06
    Therapeutic response trial
    Why
    Test fan, positioning, bronchodilator, oxygen for hypoxaemia or low-dose opioid against a stated symptom and safety outcome.
    Interpretation and limitations
    Repeated individual response is the practical gold standard for continuing symptom treatment; stop ineffective or excessively sedating measures.

Differential diagnosis

01

Airway obstruction

Stridor, wheeze, tumour compression, mucus plug or aspiration produces localised airway signs and may require bronchoscopy, stenting or emergency airway care.

02

Pleural or parenchymal disease

Effusion, pneumonia, lymphangitis, fibrosis and pneumothorax cause differing percussion, auscultation and imaging patterns and may offer targeted treatment.

03

Cardiovascular breathlessness

Pulmonary oedema, tamponade, arrhythmia and embolism are suggested by orthopnoea, oedema, chest pain, haemodynamic change or abrupt onset.

04

Metabolic or haematological drive

Anaemia, acidosis, fever and sepsis raise respiratory demand without primary lung pathology and require cause-specific laboratory assessment.

05

Anxiety and dysfunctional breathing

Panic, tingling, sighing and rapid upper-chest breathing may dominate, but physiological emergencies must be excluded before attributing symptoms to anxiety.

Management

01Acute deteriorationTreat emergency and distress togetherFirst stepBreathlessness has developed suddenly, intensified rapidly or is accompanied by instability or red flags.+
  1. 1Use ABCDE, position and reassure, provide oxygen to the appropriate target when hypoxaemic and activate emergency support within known treatment limits.
  2. 2Treat the suspected mechanism promptly and obtain focused tests that can change antibiotics, diuresis, anticoagulation, drainage, airway treatment or ventilatory support.
  3. 3Give proportionate symptom relief, communicate uncertainty and document the current ceiling, location and next review rather than treating DNACPR as no treatment.
02Chronic refractory symptomLayer non-drug and medicine careBreathlessness persists despite reasonable optimisation of the underlying advanced disease.+
  1. 1Teach upright recovery position, cool facial airflow, breathing control, pacing and energy conservation and address fear and caregiver response.
  2. 2Use a monitored low-dose opioid trial when appropriate, oxygen only for hypoxaemia or proven individual benefit and anxiolytic only for severe associated anxiety after review.
  3. 3Measure the patient's functional target, rescue use, cognition, respiratory safety and treatment burden and stop components without meaningful benefit.
03Breathlessness crisisUse a rehearsed home responseA known patient develops a severe episode in the community within an agreed palliative plan.+
  1. 1Carer stays with the patient, uses the recovery position, fan and calm short prompts and gives prescribed route-appropriate rescue without stacking doses.
  2. 2EscalationCall the named clinical or emergency service according to red flags and the escalation plan and identify any oxygen, patch, pump or medicine error.
  3. 3After recovery, review trigger, rescue effect, caregiver distress and whether the disease treatment, supply, dosing or ceiling needs change.
04Escalation decisionSeparate each respiratory interventionEscalationVentilation, hospital transfer, drainage or another burdensome treatment may be required during progressive illness.+
  1. 1Assess decision-specific capacity and explain the likely benefit, burden and alternatives for each intervention, including a time-limited treatment trial where appropriate.
  2. 2If capacity is absent, apply any valid advance refusal or authorised proxy and otherwise use a documented best-interests process informed by prior goals.
  3. 3Record CPR separately, specify treatment that remains active and share the plan across community, ambulance and hospital services with a review trigger.
Key medicines and prescribing safety4 treatments · regimens, roles and cautions+
Reduces the central perception and distress of refractory breathlessness after reversible causes and non-drug measures are addressed.

Immediate-release oral morphine for refractory breathlessness

In an opioid-naive frail adult, a local palliative protocol may begin with 2 to 2.5 mg orally as needed or at a defined interval and titrate from response; verify the exact regimen, maximum and review timing and use a renal-appropriate alternative when morphine is unsuitable.

Monitor arousability, respiratory rate and effort, hallucinations, myoclonus, nausea and constipation; renal impairment and concurrent sedatives raise toxicity risk.

May reduce panic that intensifies breathlessness but does not treat hypoxaemia, bronchospasm, fluid or obstruction.

Lorazepam for severe breathlessness-related anxiety

When anxiety remains severe despite non-drug measures and other causes are addressed, use 500 micrograms orally or sublingually as a patient-specific as-needed dose under the local palliative protocol, with a clear minimum interval and review.

Not first-line for breathlessness itself; opioids, alcohol, frailty, hypercapnia and hepatic impairment increase sedation, falls, delirium and respiratory risk.

Relieves reversible airflow obstruction and wheeze in COPD, asthma or tumour-associated bronchospasm.

Salbutamol for bronchospasm

Give 100 to 200 micrograms by metered-dose inhaler through a suitable spacer as needed, or a protocol-guided nebulised dose when severe symptoms or inhaler technique requires it.

Review technique and response; tremor, tachycardia, hypokalaemia and arrhythmia occur, and a

Complications

01

Respiratory failure

Progressive hypoxaemia, hypercapnia and muscle fatigue can cause delirium, coma, arrest and loss of safe oral medicine administration.

02

Activity restriction

Fear of symptoms drives immobility, deconditioning, thrombosis, pressure damage and dependence, which further increases breathlessness for any task.

03

Panic and anticipatory distress

Repeated frightening episodes produce hypervigilance, insomnia and emergency attendance even when background respiratory physiology remains relatively stable.

04

Treatment toxicity

Indiscriminate oxygen, opioid, benzodiazepine or diuretic use can cause hypercapnia, sedation, falls, renal injury and delayed recognition of deterioration.

05

Caregiver crisis

Witnessing apparent suffocation can cause panic, repeated ambulance calls and unsafe medicine administration without a rehearsed explanation and response plan.

Monitoring and follow-up

  • Review the patient's breathlessness rating, recovery time, sleep and chosen activity after each intervention or clinical change.
  • Measure arousability, respiratory rate and effort and cognition during opioid or benzodiazepine initiation and after every increase.
  • Check oxygen target, equipment, smoking and fire safety, tubing hazards and individual symptom benefit rather than continuing by habit.
  • Track renal and hepatic function, hydration and interacting sedatives when pharmacological symptom control is used.
  • Count rescue doses and identify triggers, onset and response to distinguish disease progression, panic, incident breathlessness and toxicity.
  • Revisit escalation, preferred place and caregiver ability after each emergency attendance or loss of function.
  • Confirm that fan, inhaler, medicines, oxygen and 24-hour contact are physically available and understood in the home.

Special situations

Saturation is not suffering

It guides oxygen and emergency assessment but does not measure the subjective intensity or fear of breathlessness.

Facial airflow is neurophysiological

Cool trigeminal stimulation can reduce perceived breathlessness and is more than simple distraction.

Opioid is not automatic sedation

A low carefully titrated dose can improve comfortable activity while excessive drowsiness signals the need to stop and reassess.

Oxygen needs a target

A cylinder without indication, saturation range and response review can add burden or worsen hypercapnia without relieving symptoms.

Panic and physiology coexist

Treating anxiety does not remove the need to examine for embolism, infection, obstruction or ventilatory failure during a changed episode.

Ceilings are treatment specific

A patient can decline invasive ventilation while accepting non-invasive support, drainage, antibiotics and active symptom management.

Common pitfalls

  1. 01

    Equating normal oxygen saturation with absence of severe breathlessness.

  2. 02

    Giving oxygen routinely without hypoxaemia or an individual benefit trial.

  3. 03

    Using a benzodiazepine before non-drug measures and reversible-cause assessment.

  4. 04

    Escalating morphine through renal decline without toxicity review.

  5. 05

    Ascribing acute deterioration to anxiety before excluding respiratory emergency.

  6. 06

    Telling a distressed patient to take deep breaths without coaching a tolerable technique.

  7. 07

    Forgetting caregiver instruction and out-of-hours access in the crisis plan.

  8. 08

    Using DNACPR as a reason to withhold antibiotics, drainage or oxygen.

  9. 09

    Starting several measures together so individual benefit and harm cannot be judged.

  10. 10

    Failing to document targets for oxygen, ventilation and hospital transfer.

silent chest
or exhaustion needs emergency care rather than repeated unsupervised doses.
Corrects hypoxaemia and may relieve breathlessness when low oxygen is a material contributor.

Supplemental oxygen for hypoxaemia

Titrate oxygen to the disease-appropriate prescribed saturation target, commonly 94 to 98 percent in most acutely ill adults or 88 to 92 percent when hypercapnic respiratory failure risk is established, while reassessing gases when indicated.

Oxygen is not routinely useful for non-hypoxaemic breathlessness; fire, smoking, dry mucosa, tubing falls, equipment burden and carbon-dioxide retention require explicit safety review.